July 15, 2019 - 17:29 — Elizabeth Wright
Today, former Vice President and 2020 Democratic presidential candidate Joe Biden offered his healthcare plan, the “Affordable Care Act 2.0.” It would keep and build on Obamacare and provide a public option or mechanism for people to buy into a government-run plan.
July 11, 2019 - 13:28 — CAGW Staff
As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny.
July 9, 2019 - 16:08 — Elizabeth Wright
Two important news items regarding pharmaceutical prices have been announced within the past week: a judge’s decision on a Trump administration rule that would have forced drug companies to provide the wholesale acquisition cost (WAC) of a drug in their television ads and a forthcoming executive order concerning drug prices.
July 8, 2019 - 13:49 — Elizabeth Wright
The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce for Medicare and Medicaid drug plans when Congress returns from the Independence Day break. Will the shallow, but damaging, policy of instituting price controls be utilized or will enhanced competitive private-sector negotiations be allowed to take hold? Because competition always leads to lower costs and more innovation, Citizens Against Government Waste (CAGW) hopes it is t
July 8, 2019 - 11:29 — CAGW Staff
As the American Medical Association’s (AMA) shrinking membership tilts further and further to the left, real questions need to be asked about the organization’s influence over the Medicare for All debate.
June 28, 2019 - 15:17 — Elizabeth Wright
Listening to the Democratic presidential debates these past two days has been alarming. Pandering to specific groups, the candidates are prepared to have the federal government cover the costs for a myriad of programs. The New York Times wrote, “The Democrats’ two nights of debates showed that liberalism is on the march in the party.
CCAGW appreciates Chairman Chuck Grassley's (R-Iowa) leadership in opposing foreign price-controlled drugs.
June 25, 2019 - 17:28 — Elizabeth Wright
The Los Angeles Times’s June 24 editorial, “San Francisco’s E-cigarette Ban Isn’t Just Bad Policy, it’s Bad for Public Health” is right on target.
June 24, 2019
Senator John Cornyn
517 Hart Senate Office Bldg.
Washington, DC 20510
Dear Senator Cornyn,
As strong supporters of free markets, property rights and innovation, we write to share our concerns about S.1416, the “Affordable Prescriptions for Patients Act of 2019,” as introduced by you and Sen. Blumenthal (D-CT).
CCAGW urges Senate HELP Committee members to oppose drug price control amendments to S. 1895.
Pages
